Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PRHSX vs FACDX overlap: 47% of top holdings shared

Bottom line

How much do PRHSX and FACDX overlap?

47% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 46.4% of PRHSX's assets and 40.0% of FACDX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

PRHSXFACDX
Weight overlap (top 25)47%
Shared holdings11
Weight in shared holdings46.4%40.0%
Total positions279154
Expense ratio0.83%0.96%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings PRHSX and FACDX have in common

Holding% of PRHSX% of FACDXOverlap
Eli Lilly & Co14.28%7.66%7.66%
Johnson & Johnson6.63%3.78%3.78%
Unitedhealth Group Inc5.99%4.17%4.17%
Abbvie Inc5.10%3.62%3.62%
Merck & Co. Inc.4.01%2.09%2.09%
Gilead Sciences Inc2.82%1.25%1.25%
Thermo Fisher Scientific Inc2.52%6.31%2.52%
Natera Inc1.44%1.65%1.44%
Danaher Corp1.43%6.75%1.43%
Guardant Health Inc1.23%1.48%1.23%
Cvs Health Corp0.94%1.29%0.94%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PRHSX

  1. Vertex Pharmaceuticals Inc — 2.28%
  2. Bristol-myers Squibb Co — 2.11%
  3. Abbott Laboratories — 1.89%
  4. Intuitive Surgical Inc — 1.87%
  5. Amgen Inc — 1.82%
  6. Stryker Corp — 1.78%
  7. Elevance Health Inc — 1.53%
  8. Cardinal Health Inc — 1.03%
  9. Royalty Pharma Plc- Cl A — 0.97%
  10. Tenet Healthcare Corp — 0.94%
  11. Kymera Therapeutics Inc — 0.89%
  12. Protagonist Therapeutics Inc — 0.85%
  13. Moderna Therapeutics Inc — 0.83%
  14. Brightspring Health Services — 0.82%

Only in FACDX

  1. Fidelity Revere Street Trust — 2.54%
  2. Argenx Se — 2.09%
  3. West Pharmaceutical Svcs Inc — 2.06%
  4. Ascendis Pharma A/s — 1.95%
  5. Alnylam Pharmaceuticals Inc — 1.78%
  6. Agilent Technologies Inc — 1.75%
  7. Viatris Inc — 1.67%
  8. 10x Genomics Inc — 1.45%
  9. Revolution Medicines Inc — 1.44%
  10. Waters Corp — 1.43%
  11. Oruka Therapeutics Inc — 1.32%
  12. Ucb Sa — 1.32%
  13. Boston Scientific Corp — 1.23%
  14. Repligen Corp — 1.22%

Asset mix

Asset typePRHSXFACDX
Stocks96.4%97.7%
Preferred stock3.0%2.1%
Cash & short-term funds0.7%2.8%
Bonds0.2%0.2%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryPRHSXFACDX
US92.6%88.0%
NL1.0%2.9%
GB1.7%2.6%
DK0.7%2.0%
BE—1.3%
KY0.5%1.3%
BM0.7%1.0%
IE0.8%1.0%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do PRHSX and FACDX overlap?
About 47% by weight. 11 securities appear in both funds' top 25 holdings; they make up 46.4% of PRHSX's assets and 40.0% of FACDX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PRHSX and FACDX have in common?
The largest shared holdings are Eli Lilly & Co, Unitedhealth Group Inc, Johnson & Johnson, Abbvie Inc, Thermo Fisher Scientific Inc.
Should I own both PRHSX and FACDX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PRHSX or FACDX?
PRHSX is broader, with 279 positions versus 154 for FACDX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.